Source Sightings
[Sutter Case Watch] Source Executive Editor Jaime King Discusses Sutter Health Settlement in Podcast
Amy Y. Gu, Managing Editor October 30, 2019
See UFCW & Employers Benefit Trust v. Sutter Health case page. As the healthcare industry grapples with the recent settlement of the antitrust case against Sutter Health, The Source Executive Editor Jaime King discusses the possible motivations and implications of this development in Tradeoffs, a healthcare podcast. In Episode 2 of the podcast, The Train Has Left the Station, Professor King points out that because Sutter is a model for many other health systems around the country, the lawsuit against Sutter’s contracting practices, including all or nothing provisions, had …
Continue Reading Download PDF
[In the Press] Interview Quoted in San Francisco Chronicle Article “Antitrust case against Sutter Health due to begin this week”
Jaime S. King, Executive Editor October 8, 2019
Jaime King was quoted in the 10/8/2019 San Francisco Chronicle article “Antitrust case against Sutter Health due to begin this week”.
Continue Reading Download PDF
[In the Press] Interview Quoted in New York Times Article “High Medical Bills Are at Center of Hospital Group’s Trial”
Jaime S. King, Executive Editor October 3, 2019
Jaime King was quoted in the 10/3/2019 New York Times article High Medical Bills Are at Center of Hospital Group’s Trial: Jaime King, a law professor at U.C. Hastings College of the Law, described the approach as “a landmark case.” Rather than trying to block a merger over antitrust concerns, the Sutter trial is an attempt to attack the practices of a powerful hospital system. “The Sutter case is challenging a whole system of behavior,” she said.
Continue Reading Download PDF
Just Published: The Source Research Brief on Legal Challenges to State Efforts to Control Drug Prices
Amy Y. Gu, Managing Editor September 24, 2019
As states increase legislative efforts to rein in prescription drug prices, an increased number of laws have been passed to regulate pharmacy benefit managers, price gouging, and price transparency in the pharmaceutical industry. However, industry groups have also stepped up legal challenges against these laws, using specifically the Dormant Commerce Clause, ERISA, and federal patent and trade secret laws. With support from the National Academy for State Health Policy (NASHP), The Source’s Katie Gudiksen, Sammy Chang, and Jaime King examine these state laws and ensuing legal challenges in the newly …
Continue Reading Download PDF
[Sutter Case Watch] Source Advisory Board Member Tim Greaney Gives Podcast Interview Regarding Sutter Health Lawsuit
Amy Y. Gu, Managing Editor September 23, 2019
As jury selection begins in the antitrust lawsuit against Sutter Health, Distinguished Fellow and Advisory Board Member Tim Greaney was interviewed in the Gist Healthcare September 23, 2019 Podcast regarding the case. Gist Healthcare is an independent strategic advisory with a weekly podcast that distills the latest healthcare news, trends and conversations with industry leaders into actionable guidance for healthcare leaders in hospital systems, physician groups and other organizations on market direction, system strategy, care transformation and payment reform. Listen to the podcast here.
Continue Reading Download PDF
[In the Press] Interview Quoted in Bloomberg Law Article “Sutter Antitrust Class Action Could Upend Industry Consolidation”
Jaime S. King, Executive Editor September 20, 2019
Jaime King was quoted in the 9/20/2019 Bloomberg Law article “Sutter Antitrust Class Action Could Upend Industry Consolidation”: Health-care costs are one of the most important concerns in the U.S., said Jaime King, associate dean of the University of California Hastings School of Law and director of the Concentration on Law and Health Sciences. “I know that attorneys general in other states are paying very close attention to what’s happening because concentration is not something that is just happening in California—it’s happening all over the country. If successful we will …
Continue Reading Download PDF
[Publication] The Judges’ Book: Health Law: SB 17 and State Regulation of Drug Pricing
Amy Y. Gu, Managing Editor August 1, 2019
The Judges’ Book: Vol. 3 , Article 12 (2019) “Health Law: SB 17 and State Regulation of Drug Pricing” Authors: Jaime S. King and Katherine L. Gudiksen
Continue Reading Download PDF